Tomas J. Heyman
CIK 1814673 · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.86M
Companies
6
Total Filings
27
Lifetime Open-Market Net
-$1.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXEL | Director | 50,649 | $56.51 | $2.86M | -$201.3K | 5 | 2026-05-29 |
| Akero Therapeutics, Inc. (AKRO) Delisted | Director | 0 | $54.65 | $0 | -$1.42M | 8 | 2025-12-09 |
| OptiNose, Inc. (OPTN) Delisted | Director | — | $9.60 | — | $0 | 6 | 2025-05-21 |
| XLO | Director | — | $9.15 | — | $0 | 2 | 2023-06-13 |
| IVVD | Director | — | $0.59 | — | $0 | 1 | 2023-05-25 |
| Invivyd, Inc. (ADGI) Delisted | Director | — | $4.64 | — | $0 | 1 | 2022-06-24 |
Recent Filings · Page 3 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | Invivyd, Inc. (ADGI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-04 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.